Chia, R. et al. (2021). “Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.” Nat Genet 53(3): 297-303.

View/Download

Archer, D. B., et al. (2020). “Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.“ Mov Disord 35(8): 1388-1395.

View/Download

Huh, Y. E., et al. (2020). “β-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters.“ Neurology 95(6): e685-e696.

View/Download

Abd Elhadi, S., et al. (2019). “α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls.“ Ann Clin Transl Neurol 6(12): 2426-2436.

View/Download

Cheran, G., et al. (2019). “Cognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers.“ J Int Neuropsychol Soc 25(2): 184-194.

View/Download

Iwaki, H., et al. (2019). “Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.” Neurol Genet 5(4): e348.

View/Download

Iwaki, H. et al. (2019). “Genomewide association study of Parkinson’s disease clinical biomarkers in 12 longitudinal patients’ cohorts.” Mov Disord 34(12): 1839-1850.

View/Download

Kang, U. J., et al. (2019). “Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.“ Mov Disord 34(4): 536-544.

View/Download

Posavi, M., et al. (2019). “Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.“ PLoS Med 16(10): e1002931.

View/Download

Pottier, C., et al. (2019). “Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.“ Acta Neuropathol 137(6): 879-899.

View/Download

Chen-Plotkin, A. S., et al. (2018). “Finding useful biomarkers for Parkinson's disease.“ Sci Transl Med 10(454).

View/Download

Goldman, J. G., et al. (2018). “Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.“ Mov Disord 33(2): 282-288.

View/Download

Pottier, C., et al. (2018). “Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.“ Lancet Neurol 17(6): 548-558.

View/Download

Gwinn, K., et al. (2017). “Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.“ Biomark Med 11(6): 451-473.

View/Download